Accueil・Liste d'Actions・Schrodinger Inc

Schrodinger Inc

Fermé

SecteurSoins de santé

17.48 -5.31

Acheter Vendre

Résumé

Variation du prix de l'action

24h

Actuel

Min

18.25

Max

18.82

Chiffres clés
By Trading Economics
Revenu	66M 6M
Ventes	302K 59M
BPA	0.08
Marge bénéficiaire	10.146
Employés	850
EBITDA	65M 7.3M

Recommandations
By TipRanks
Recommandations	Achat Fort
Prévisions sur 12 Mois	+8.7% upside

Dividendes
By Acuity
Prochains Résultats	4 nov. 2026

Statistiques du Marché
By TradingEconomics
Capitalisation Boursière	217M 1.4B
Ouverture précédente	22.79
Clôture précédente	17.48

Sentiment de l'Actualité

By Acuity

64%

36%

290 / 340 Classement par Healthcare

Schrodinger Inc Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

12 août 2026, 19:26 UTC

Macro Event

Correlated Moves

Shares higher during the session, influenced by the ETF's increase.

11 août 2026, 19:16 UTC

Shares of Schrodinger Inc. are trading higher, maintaining a position above the 20-day moving average amid no specific company news.

10 août 2026, 19:36 UTC

Schrodinger Inc's shares are higher today, continuing a six-day advance amid supportive market conditions and heightened geopolitical tensions affecting investor sentiment.

7 août 2026, 19:16 UTC

Correlated Moves

Schrodinger Inc shares are higher today, supported by a broader market trend and gains in the Russell 2000 Index, despite some macroeconomic uncertainties.

6 août 2026, 23:01 UTC

Schrodinger Inc shares declined in after-market trading, reversing gains from the previous four sessions. The stock remains above its 20-day moving average.

5 août 2026, 23:01 UTC

News

Schrodinger Inc reported second-quarter adjusted EPS of $0.08, surpassing estimates. Revenue reached $58.889 million, leading to higher after-market trading.

3 août 2026, 19:51 UTC

Correlated Moves

Schrodinger Inc shares are higher, reflecting broader market gains amid a drop in oil prices and positive sentiment in the technology sector.

31 juil. 2026, 19:46 UTC

Correlated Moves

Schrodinger Inc shares are lower amid declining first-quarter results and broader market pressure, despite an earlier rebound from session lows.

30 juil. 2026, 18:46 UTC

Correlated Moves

Schrodinger Inc. advanced during Thursday's session, supported by broader market gains despite earlier pulling back from a session high.

29 juil. 2026, 20:51 UTC

Correlated Moves

Schrodinger Inc shares are lower in after-market trading, influenced by a broader market downturn and rising crude oil prices amid geopolitical tensions.

28 juil. 2026, 23:01 UTC

Schrodinger Inc. shares declined in after-market trading, remaining below their 20-day moving average amid broader market strength and pressure on technology stocks.

27 juil. 2026, 22:51 UTC

Schrodinger Inc. shares are higher in after-market trading, despite remaining below their 20-day moving average amid broader market dynamics and falling crude oil prices.

24 juil. 2026, 15:11 UTC

Schrodinger Inc shares are declining today, continuing a downward trend since Thursday's close. A pullback in crude oil prices may be affecting investor sentiment.

20 juil. 2026, 15:12 UTC

Correlated Moves

Schrodinger Inc. shares are lower amid a decline in the ARK Genomic Revolution ETF and broader market pressures, despite a slight rebound earlier in the session.

Comparaison

Variation de prix

Schrodinger Inc prévision

Objectif de Prix

By TipRanks

8.7% hausse

Prévisions sur 12 Mois

Moyen 20.25 USD 8.7%

Haut 24 USD

Bas 17 USD

Basé sur 6 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat Fort

6 ratings

Achat

Maintien

Vente

Basé sur 6 qui ont noté l'action Microsoft Corp. au cours des 3 derniers mois.

Sentiment

By Acuity

290 / 340Classement par Soins de santé

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

À Propos Schrodinger Inc

Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. The company serves biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide. It has a research collaboration and license agreement with Novartis AG to advance multiple development candidates. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.